B. Vergès
Endocrinology, Diabetes and Metabolism · 2015
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Endocrinology, Diabetes and Metabolism — 5 citations into it
Whom B. Vergès trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from B. Vergès's perspective
Ordered by how strongly the researchers B. Vergès trusts endorse each paper. Same corpus, a different order for every researcher.
- Diabetic dyslipidaemia: from basic research to clinical practice* (Diabetologia)
- Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex (Diabetologia)
- Overproduction of large VLDL particles is driven by increased liver fat content in man (Diabetologia)
- Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition (Arteriosclerosis, Thrombosis and Vascular Biology)
- Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. (Diabetes)
- Molecular regulation of HDL metabolism and function: implications for novel therapies. (Journal of Clinical Investigation)
- Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. (Journal of Clinical Endocrinology and Metabolism)
- Global and societal implications of the diabetes epidemic (Nature)
- Safety of anacetrapib in patients with or at high risk for coronary heart disease. (New England Journal of Medicine)
- Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. (Diabetes)
Their papers
- Pathophysiology of diabetic dyslipidaemia: where are we? (2015) — 626 citations